A measles-vectored vaccine candidate expressing prefusion-stabilized SARS-CoV-2 spike protein brought to phase I/II clinical trials: candidate selection in a preclinical murine modelJérémy Brunet, Nicolas Escriou|Journal of Virology|2024Cited by 1